Ambulatory Medication Safety Events in High-risk Patients With Diabetes Before and After a COVID-19 Clinic Slowdown
- 10 April 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Patient Safety
- Vol. 21 (4) , 240-245
Abstract
Objectives: We aimed to assess possible changes in medication safety over a mandatory pre-/post- COVID-19 clinic slowdown in a high-risk population of patients with diabetes seen at a safety net clinic. Methods: Retrospective chart review of all patient encounters 1 year before and after the slowdown. The study cohort were all patients with poorly controlled diabetes established pre-COVID-19 who were prescribed 4+ chronic medications. Each clinic note was abstracted for reports of any medication-related problems. The primary outcomes were measures of health care system utilization and potential adverse drug events (ADEs). Results: Out of 762 patients with diabetes, 59 were poorly controlled and formed the high-risk study cohort: age 53.0±11 years, 69% female, 17% White, 29% Hispanic, and 43% African American. There were similar numbers of patient encounters pre-/post-slowdown (7.68 clinic visits vs. 4.2 clinic visits plus 3.19 telehealth visits), cancellations (2.54 vs. 2.97), and no-shows (2.17 vs. 1.98). There was no change in the number of prescribed medications pre-/post-slowdown (12.1 vs. 11.7), but more potential adverse medication events (6/380 (1.6%) vs. 17/429 (4.0%), P=0.04). Of all abstracted medication-related problems, the majority were in diabetic medications 57/78 (73.1%), and of those, most involved insulin 43/57 (75.4%). Eleven preventable ADEs over the 2-year period were observed, all involved insulin, and were often affected by patient work system challenges such as self-administration and timing. Conclusions: There was a small increase in potential adverse medication events among a cohort of high-risk patients during the COVID-19 pandemic. The most common ADE was hypoglycemia associated with insulin.Keywords
This publication has 23 references indexed in Scilit:
- Telehealth Expansion, Internet Speed, and Primary Care Access Before and During COVID-19JAMA Network Open, 2024
- Virtual Visits With Own Family Physician vs Outside Family Physician and Emergency Department UseJAMA Network Open, 2023
- Association of Health-Related Social Needs With Quality and Utilization Outcomes in a Medicare Advantage Population With DiabetesJAMA Network Open, 2023
- Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin, 1988-2020JAMA Network Open, 2022
- Comparison of Quality Performance Measures for Patients Receiving In-Person vs Telemedicine Primary Care in a Large Integrated Health SystemJAMA Network Open, 2022
- Association of Health Literacy and Area Deprivation With Initiation and Completion of Telehealth Visits in Adult Medicine Clinics Across a Large Health Care SystemJAMA Network Open, 2022
- Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialThe American Journal of the Medical Sciences, 2022
- Treatment and Follow-up Care Associated With Patient-Scheduled Primary Care Telemedicine and In-Person Visits in a Large Integrated Health SystemJAMA Network Open, 2021
- US Emergency Department Visits Attributed to Medication Harms, 2017-2019JAMA, 2021
- Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for TelemedicineJAMA Internal Medicine, 2020